Skip to main navigation Skip to search Skip to main content

Activation of ERBB2 Signaling Causes Resistance to the EGFR-Directed Therapeutic Antibody Cetuximab

  • Yong Gon Cho

Research output: Contribution to journal › Journal article › peer-review

585   Link opens in a new tab Scopus citations
Original languageKorean
JournalScience Translational Medicine
StatePublished - 2011.09.7

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Cite this